Research and Clinical Applications of Targeting Gastric Neoplasms($123.75Value)

Description

Research and Clinical Applications of Targeting Gastric Neoplasms provides a comprehensive overview of gastrointestinal cancers, covering preclinical research and clinical findings related to risk factors, current treatment regimens (including immunotherapy), screening/detection methods, etiology of disease, precision medicine and future perspectives. Gastrointestinal cancers rank among the most lethal and common worldwide, and as such, there is intense research into their diverse causes and treatment options. This reference provides a consolidation of the research, making it a perfect resource for basic science and clinical researchers as well as oncologists who work in gastroenterology and GI tract cancer fields. Provides comprehensive coverage of preclinical research and the clinical aspects of gastric cancer - Presents future perspectives from leading researchers in the field who provide the potential for furthering research topics - Combines the expertise of researchers in GI tracts, cancer, immunity, immunology, infectious disease and microbiology for an interdisciplinary approach Presents comprehensive overview of preclinical research and clinical findings in gastrointestinal cancers Research and Clinical Applications of Targeting Gastric Neoplasms provides a comprehensive overview of gastrointestinal cancers, incorporating preclinical research and clinical findings related to risk factors, current treatment regimens (including immunotherapy), screening/detection methods, etiology of disease, precision medicine and future perspectives. Gastrointestinal cancers rank among the most lethal and common worldwide, and as such there is intense research into their diverse causes and treatment options leading to an overabundance of content. This reference provides consolidation of this research making it possible to provide complete coverage of the area making it the perfect resource for basic science and clinical researchers of the gastric system; as well as oncologists, in the gastroenterology and GI tract cancer fields. Prof. Brendan Jenkins is an internationally renowned researcher who studies inflammation-associated cancers of the stomach, pancreas and lung, the latter of which is also linked to chronic obstructive pulmonary disease (COPD). His vision is to identify and develop new diagnostics and immunotherapies for these diseases. Prof. Jenkins is head of the Cancer and Immune Signaling Laboratory of the Hudson Institute of Medical Research in Victoria, Australia, and he is also a Professor in the Faculty of Medicine, Nursing and Health Sciences of Monash University. He has received over 20 national and international awards for his research and is a Senior Research Fellow of the Australian National Health and Medical Research Council (2014-2023); prior to that he held a prestigious Viertel Senior Medical Research Fellowship (2009-2013). He received his PhD in Medicine from the University of Adelaide, South Australia in 1998.